RxSight, Inc.
RXST
$8.43
$0.212.56%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 33.64M | 37.90M | 40.21M | 35.31M | 34.89M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 33.64M | 37.90M | 40.21M | 35.31M | 34.89M |
| Cost of Revenue | 8.45M | 9.57M | 11.43M | 10.09M | 10.64M |
| Gross Profit | 25.19M | 28.33M | 28.79M | 25.22M | 24.25M |
| SG&A Expenses | 28.98M | 28.64M | 28.22M | 25.63M | 24.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 47.64M | 48.57M | 48.84M | 44.54M | 43.22M |
| Operating Income | -14.00M | -10.67M | -8.63M | -9.23M | -8.33M |
| Income Before Tax | -11.75M | -8.17M | -5.93M | -6.33M | -6.06M |
| Income Tax Expenses | 32.00K | 18.00K | 12.00K | 13.00K | 16.00K |
| Earnings from Continuing Operations | -11.79M | -8.19M | -5.94M | -6.34M | -6.08M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -11.79M | -8.19M | -5.94M | -6.34M | -6.08M |
| EBIT | -14.00M | -10.67M | -8.63M | -9.23M | -8.33M |
| EBITDA | -13.22M | -9.90M | -8.11M | -8.09M | -7.52M |
| EPS Basic | -0.29 | -0.20 | -0.15 | -0.16 | -0.16 |
| Normalized Basic EPS | -0.18 | -0.13 | -0.09 | -0.10 | -0.10 |
| EPS Diluted | -0.29 | -0.20 | -0.15 | -0.16 | -0.16 |
| Normalized Diluted EPS | -0.18 | -0.13 | -0.09 | -0.10 | -0.10 |
| Average Basic Shares Outstanding | 40.74M | 40.51M | 40.36M | 39.79M | 38.46M |
| Average Diluted Shares Outstanding | 40.74M | 40.51M | 40.36M | 39.79M | 38.46M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |